View in EDS HTML Full Text PDF Full Text

Efficacy and toxicity of post-neoadjuvant trastuzumab emtansine in HER2-positive breast cancer patients treated at Institut Curie Hospitals.

Saved in:
Bibliographic Details
Title: Efficacy and toxicity of post-neoadjuvant trastuzumab emtansine in HER2-positive breast cancer patients treated at Institut Curie Hospitals.
Authors: De Moura, Alexandre1 (AUTHOR) alexandre.demoura@curie.fr, Gleizes, Orane2 (AUTHOR), Cabel, Luc1 (AUTHOR), Bethune-Volters, Anne1 (AUTHOR), Bellesoeur, Audrey1 (AUTHOR), Bello-Roufai, Diana1 (AUTHOR), Cottu, Paul1,3 (AUTHOR), Sebbag, Clara1 (AUTHOR), Loirat, Delphine1 (AUTHOR), Geiss, Romain1 (AUTHOR), Pierga, Jean-Yves1,3 (AUTHOR), Escalup, Laurence2 (AUTHOR), Bidard, François Clément1,4 (AUTHOR), Genevée, Thomas2 (AUTHOR)
Source: Scientific Reports. 11/7/2025, Vol. 15 Issue 1, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-025-24849-0